Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Winfastorlose who wrote (9015)	4/6/2020 6:01:21 AM
From: w0z	2 Recommendations Recommended By the traveler Winfastorlose Read Replies (1) \| Respond to of 26506

And CommunistNegativeNews (CNN) is in full-out attack mode for Trump recommending doctors try hydroxychloroquine. That alone is a resounding endorsement of it. twitter.com

To: Winfastorlose who wrote (9015)	4/6/2020 10:39:56 AM
From: ajtj99	3 Recommendations Recommended By beagle57 ItsAllCyclical Kirk © Read Replies (1) \| Respond to of 26506

I notice Acetaminophen and "nothing" are just behind, at 31% and 32% respectively. Doing "Nothing" is rated only 5% less effective than the miracle drug on that chart.

To: Winfastorlose who wrote (9015)	4/6/2020 10:46:57 AM
From: Kirk ©	1 Recommendation Recommended By ajtj99 Respond to of 26506

That is a great example of why you really need Phase 1, 2 & 3 trials to compare against placebos and normalize out other medications patients are taking that might prevent or lessen the severity of Covid-19. Obviously, if something like Hydroxycholoquine has good evidence of working, most MDs will prescribe it for their patients if available. So it is a great reason to not give me (I looked into getting it the day the first paper surfaced on Googledocs), Jim Cramer or anyone else that drug unless they need a 2 week supply for Lupus or are sick in a hospital about to go on a vent.... until they finish some early studies and get hundreds of millions of doses.